Clinical Trial Update: Moxifloxacin in Adjuvant Treatment of Patients With Operable Breast Cancer [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating moxifloxacin as adjuvant treatment for operable breast cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Moxifloxacin (moxifloxacin)

Snippet

Sponsor: Sun Yat-sen University | Conditions: Breast Cancer | Phase 3 | Status: COMPLETED